American Oncology Network, Inc.
AONC · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $1 | $0 |
| Revenue | $2 | $1 | $1 | $1 |
| % Growth | 37.5% | 11.3% | 21.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 6.7% | 6.5% | 8.3% | 8.3% |
| EBITDA | $0 | -$0 | $0 | $0 |
| % Margin | 0.1% | -3.1% | 2% | 0.8% |
| Net Income | -$0 | -$0 | $0 | -$0 |
| % Margin | -0.2% | -0.4% | 0.2% | -0% |
| EPS Diluted | -0.69 | -1.36 | 0.062 | -0.003 |
| % Growth | 49.3% | -2,290% | 2,584% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |